a

Swiss trademark · 504753 · Combined mark · Deleted

Register entry

Registration number
504753
Application number
07051/2002
Status
Deleted
Type
Combined mark
As registered
a ((fig.))
Filed
Aug 14, 2002
Registered
Oct 31, 2002
Published
Nov 14, 2002
Deleted
Mar 18, 2013
Reason
Not renewed
Priority
15.02.2002 US
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung von dermatoligischen Erkrankungen, Autoimmunerkrankungen, Entzündungserkrankungen, Psoriasis und rheumatoide Arthritis.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 18, 2013

    Deleted, not renewed

    Published in Swissreg on 18.03.2013

  2. Apr 30, 2007

    Transferred

    Owner
    Biogen Idec MA Inc., 14 Cambridge Center, Cambridge, MA 02142, USA → Astellas US LLC, Three Parkway North, Deerfield, IL 60015, USA
    Representative
    E. Blum & Co., Patentanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 82 of 30.04.2007

  3. Sep 20, 2004

    Holder’s address changed

    Owner
    Biogen, Inc., 14 Cambridge Center, Cambridge (MA 02142), USA → Biogen Idec MA Inc., 14 Cambridge Center, Cambridge, MA 02142, USA

    Published in the SOGC no. 182 of 20.09.2004

  4. Nov 14, 2002

    Registered

    Published in the SOGC no. 221 of 14.11.2002

Parties

Holder

Astellas US LLC

Three Parkway North, Deerfield, IL 60015, US

Agent

E. Blum & Co. AG

E. Blum & Co. AG Patent- und Markenanwälte VSP

Vorderberg 11, 8044 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.